Modulation of Adriamycin Resistance in Human Breast Carcinoma MCF‐7 Cells in vitro and in vivo by Medroxyprogesterone Acetate

The combination effect of adriamycin (ADM) and medroxyprogesterone acetate (MPA) was examined in vitro against human breast carcinoma MCF‐7 and its ADM‐resistant line (MCF‐7/ADM). MCF‐7 cells, which are positive for estrogen receptors, progesterone receptors and high‐affinity MPA‐binding activity, w...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Jpn J Cancer Res
Autori principali: Ishida, Hiroyuki, Okabe, Masami, Gomi, Katsushige, Horiuchi, Ryuya, Mikami, Koji, Naito, Mikihiko, Tsuruo, Takashi
Natura: Artigo
Lingua:Inglês
Pubblicazione: Blackwell Publishing Ltd 1994
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5919497/
https://ncbi.nlm.nih.gov/pubmed/8014112
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.1994.tb02393.x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi